跳至主要内容
临床试验/NCT00421018
NCT00421018已完成不适用

Optimization of the Anti-Inflammatory Treatment of Asthma Patients Through Exhaled NO Measurements for Increased Asthma-Related Quality of Life in Primary Health Care (NOAK)

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 187 人开始时间: 2006年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
187
试验地点
1
主要终点
Mini-AQLQ (Asthma-Related Quality of Life)

研究概览

简要总结

The purpose of this study is to determine whether use of exhaled NO (nitric oxide) to regulate the anti-inflammatory treatment leads to increased asthma-related quality of life in patients with allergic asthma

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-64
  • Clinical diagnosis of Asthma
  • Glucocorticoid treatment > 6 months.
  • Verified Allergy
  • Read and speak Swedish

排除标准

  • Current regular treatment with long-acting beta2-agonist
  • Treatment with Singulair only or in combination with glucocorticoids
  • Taking part in other research study
  • Pregnancy or breast-feeding
  • Unstable Asthma

研究组 & 干预措施

Symptom-guided group

Sham Comparator

Anti-inflammatory treatment is guided conventionally according to symptoms and beta-2-agonist use.

干预措施: Single corticosteroid inhalers and Singulair (Drug)

FeNO-guided group

Active Comparator

Anti-inflammatory treatment is guided according to the level of exhaled nitric oxide

干预措施: Single corticosteroid inhalers and Singulair (Drug)

结局指标

主要结局

Mini-AQLQ (Asthma-Related Quality of Life)

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验